University of Alberta
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1908-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ualberta.ca
Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)
Not Applicable
Completed
- Conditions
- Covid19COVID-19 PneumoniaSARS-CoV2 InfectionCOVID-19 Lower Respiratory InfectionCOVID-19 Acute Respiratory Distress SyndromeSARS-CoV-2 Acute Respiratory Disease
- Interventions
- Behavioral: Antimicrobial stewardship prospective audit and feedback
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 833
- Registration Number
- NCT04896866
- Locations
- 🇨🇦
Grey Nuns Community Hospital, Edmonton, Alberta, Canada
🇨🇦University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦Misericordia Community Hospital, Edmonton, Alberta, Canada
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 600
- Registration Number
- NCT04888481
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.
Phase 1
Completed
- Conditions
- Group A Streptococcal Infection
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT04882514
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Not Applicable
Completed
- Conditions
- BronchiectasisPulmonary TuberculosisProgressive Fibrosing Interstitial Lung DiseaseLung TransplantCystic Fibrosis
- Interventions
- Device: ADAMM- RSM Device
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 8
- Registration Number
- NCT04857814
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Rivaroxaban in Type 2 Myocardial Infarctions
Phase 2
Completed
- Conditions
- Type II Myocardial Infarction
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 8
- Registration Number
- NCT04838808
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Role of Repeat Resection in Recurrent Glioblastoma
Not Applicable
Recruiting
- Conditions
- Recurrent GlioblastomaGlioblastoma - Category
- Interventions
- Procedure: Repeat Surgical Management of Recurrent GBM
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 250
- Registration Number
- NCT04838782
- Locations
- 🇨🇦
University of Alberta Division of Neurosurgery, Edmonton, Alberta, Canada
Synbiotics and Post-op Crohn's Disease
Not Applicable
Terminated
- Conditions
- Crohn's Disease
- Interventions
- Other: Digestible MaltodextrinDietary Supplement: Synbiotic
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 4
- Registration Number
- NCT04804046
- Locations
- 🇨🇦
Misericordia Community Hospital, Edmonton, Alberta, Canada
🇨🇦Grey Nuns Community Hospital, Edmonton, Alberta, Canada
🇨🇦University of Alberta Human Nutrition Research Unit, Edmonton, Alberta, Canada
Corticosteroids for COVID-19
Phase 3
Withdrawn
- Conditions
- Covid19
- Interventions
- Device: Point of Care testing device for C-reactive protein
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- University of Alberta
- Registration Number
- NCT04795583
- Locations
- 🇨🇴
Clinica de la Mujer, Bogotá, Colombia
🇲🇽ABC Medical Center, Mexico City, Mexico
Online Wellness Intervention for Primary Biliary Cholangitis (PBC)
Not Applicable
Completed
- Conditions
- Primary Biliary Cirrhosis
- Interventions
- Behavioral: Mind-body therapy
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 34
- Registration Number
- NCT04791527
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Antibiotic Prophylaxis for Neurogenic Bladder Botox
Phase 2
Recruiting
- Conditions
- Neurogenic BladderPost-operative Urinary Tract Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 160
- Registration Number
- NCT04791579
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath